WebJun 14, 2024 · Novavax shares closed last week at $209.68, giving the company a market value of $15.5 billion. To supporting its coronavirus work, the biotech has nearly … Web2 days ago · Novavax's Q4 revenue increased 61% year-over-year to $357 million, which missed average analyst estimates of $383.14 million. In its 10K filing, the company said the U.S. government did not...
Novavax Plans to Cut $50 Million in Costs, COVID-19 Vaccine …
WebNovavax, Inc. (NVAX) Recent Insider Transactions - Yahoo Finance Novavax, Inc. (NVAX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 8.59 +0.59 … WebApr 4, 2024 · Investor inquiries. Shareholders seeking information can contact investor relations at (240) 268-2024 or email us at [email protected]. Novavax corporate policy … north carolina state maps free
NVAX Novavax Inc. Company Profile & Executives - WSJ
WebApr 15, 2024 · During the same quarter in the previous year, the business posted ($11.18) EPS. Novavax’s quarterly revenue was up 60.8% on a year-over-year basis. Want More Great Investing Ideas? WebApr 12, 2024 · NASDAQ:NVAX opened at $9.04 on Wednesday. Novavax, Inc. has a 12-month low of $5.61 and a 12-month high of $76.77. The firm has a market capitalization of $778.98 million, a P/E ratio of -1.08 and a beta of 1.73. The stock's fifty day simple moving average is $8.11 and its 200-day simple moving average is $13.33. Web2 days ago · Let’s say that Novavax gets 15% of that revenue. That equates to $3.9 billion. Meanwhile, revenue from flu vaccines came in at $4.28 billion in 2024. Let’s say the market grows to $4.5 billion... north carolina state medical board